Embryoman
A 2025 study re-analyzed embryos that tested as mosaic by NGS-based PGT-A using SNP karyotyping and found that one-third of those “mosaics” were actually uniformly aneuploid.
A 2025 study found that RIF and RPL patients with abnormal EMMA & ALICE results that had antibiotic and/or probiotic treatment showed similar pregnancy rates to those with normal EMMA & ALICE results.
A 2025 opinion article highlights some of the issues with PGT-A, mainly its uncertain benefit, technical flaws, high costs, and the risk of discarding potentially viable embryos.
A new study performed an “umbrella review” on the use of supplements for improving female infertility, finding that while studies show improvements in pregnancy outcomes, the quality of the data is low and “insufficient to recommend nutrient supplementation.”
A 2024 study combined the results of 14 studies analyzing how hysteroscopy impacts IVF success, finding improvements in live birth rate, pregnancy rate and no change in miscarriage rate.
A 2025 study found that live birth rates increased with endometrial thickness up to about 9 mm, after which they plateaued.
A new study reviewed how fibroids can compromise the endometrium and prevent embryo implantation, identifying key issues such as disrupted blood flow and vascular changes, abnormal endometrial peristalsis, inflammatory responses, and changes in the microbiome.
A 2024 meta-analysis combined the results of 12 studies comparing the use of artificial oocyte activation (AOA) on IVF outcomes. They found that there were increases in fertilization and live birth rates, but only in patients with a history of fertilization problems.
A 2024 meta-analysis combined the results of 12 studies comparing different IVF trigger shots, including hCG, GnRH agonist, and dual and double triggers. Triggers showed variable outcomes, highlighting the need for a personalized medicine approach.
Researchers, in a 2024 study, have discovered that mutations in genes that code for specialized proteins called kinesins could lead to increased risk of aneuploidy and accelerate the aging process.
A 2024 study found that working past 4 pm, specific procedures, and variability among embryologists all contribute to errors in IVF labs.
A 2024 study compared cumulative live birth rates for patients aged 40 to 48, finding that increasing age led to decreasing chances of birth.
A 2024 study explored the male and female factors that are associated with embryo euploid rates, finding that male characteristics had a minor influence.
